Colorectal Cancer Clinical Panel
Guidance for developing supported self-management interventions for cancer survivors
A guidance document was produced and distributed to hospitals and cancer service providers outlining an evidence-based methodology for the development and implementation of supported self-management support. The guidance illuminated a process of: a needs assessment plan, determining intervention typology, selecting a theoretical framework, an intervention delivery strategy, selecting intervention techniques, activating an implementation plan, and ongoing evaluation. Key stakeholder outcomes to consider were also provided, including patient, clinician, commissioner, and policymaker outcomes.
I have worked with Nicola on several occasions: she has great skills in medical writing, research interview moderation, and beyond. I wouldn’t hesitate to recommend her.
Top 10 Pharma Company
Chief Medical Officer, IDEA Pharma
The meeting objective was to gain external expert opinion on a pharma company’s approach to drug development in colorectal cancer through review of current assets and development plans, and examination of other potential platforms and targets to complement the portfolio.
A 2.5 hour face-to-face advisory board was convened during the American Society of Clinical Oncology (ASCO) 2023 in Chicago. The meeting was attended by eight pharma representatives and five external advisors who work in colorectal cancer. Topics of discussion included how to proceed with research on promising therapeutics, other potential mechanisms of action to explore, and whether knowledge gained at ASCO should impact decision-making.
A 10,000-word meeting report to guide strategic decision-making around current and future assets.